Institutional Ownership
Moonlake Immunotherapeutics
CUSIP 61559X104CLASS A ORDMLTXQ1 2026
Institutional Holders
142
13F filers
Shares Held
62.80M
Aggregate institutional
Institutional Value
$1.13B
Q1 2026
Net New Holders
+16
37 new · 21 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions37
Increased48
Decreased41
Sold out21
Institutional Holders
142 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bvf Inc/Il | 16.00M | $298.26M | −3.75M | Reduced |
| 2 | Deep Track Capital, LP | 6.41M | $119.46M | +1.80M | Added |
| 3 | Cormorant Asset Management, LP | 4.48M | $83.52M | +125.0K | Added |
| 4 | Janus Henderson Group PLC | 3.45M | $64.30M | +1.36M | Added |
| 5 | D. E. Shaw & Co., Inc. | 2.39M | $44.56M | −90.1K | Reduced |
| 6 | Mpm Bioimpact LLC | 1.81M | $33.76M | +1.81M | New |
| 7 | Weiss Asset Management LP | 1.71M | $31.84M | +1.71M | New |
| 8 | Logos Global Management LP | 1.50M | $27.96M | −250.0K | Reduced |
| 9 | Point72 Asset Management, L.P. | 1.37M | $25.51M | +596.0K | Added |
| 10 | Citadel Advisors LLC | 1.32M | $24.67M | +942.8K | Added |
132 more institutional holders on Premium
See every fund holding Moonlake Immunotherapeutics, with full quarter-over-quarter share changes.
Unlock all holders